SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600620-23-000004
Filing Date
2023-04-05
Accepted
2023-04-05 08:16:07
Documents
28
Period of Report
2023-04-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K auph-20230405.htm   iXBRL 8-K 34008
2 EX-99.1 exhibit991renalbiopsysubst.htm EX-99.1 20679
3 EX-99.2 finalrenalbiopsysub-stud.htm EX-99.2 15413
7 finalrenalbiopsysub-stud001.jpg GRAPHIC 75304
8 finalrenalbiopsysub-stud002.jpg GRAPHIC 49017
9 finalrenalbiopsysub-stud003.jpg GRAPHIC 119784
10 finalrenalbiopsysub-stud004.jpg GRAPHIC 130229
11 finalrenalbiopsysub-stud005.jpg GRAPHIC 140712
12 finalrenalbiopsysub-stud006.jpg GRAPHIC 126258
13 finalrenalbiopsysub-stud007.jpg GRAPHIC 104756
14 finalrenalbiopsysub-stud008.jpg GRAPHIC 78859
15 finalrenalbiopsysub-stud009.jpg GRAPHIC 112966
16 finalrenalbiopsysub-stud010.jpg GRAPHIC 77453
17 finalrenalbiopsysub-stud011.jpg GRAPHIC 76933
18 finalrenalbiopsysub-stud012.jpg GRAPHIC 75468
19 finalrenalbiopsysub-stud013.jpg GRAPHIC 83998
20 finalrenalbiopsysub-stud014.jpg GRAPHIC 75304
  Complete submission text file 0001600620-23-000004.txt   2040791

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20230405.xsd EX-101.SCH 1936
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20230405_lab.xml EX-101.LAB 23924
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20230405_pre.xml EX-101.PRE 12622
22 EXTRACTED XBRL INSTANCE DOCUMENT auph-20230405_htm.xml XML 4113
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 23801234
SIC: 2834 Pharmaceutical Preparations